[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
Identifieur interne : 002883 ( PubMed/Checkpoint ); précédent : 002882; suivant : 002884[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
Auteurs : Amélie Guihot [France] ; François Bricaire ; Taisheng Li ; Philippe BossiSource :
- Presse medicale (Paris, France : 1983) [ 0755-4982 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (usage thérapeutique), Asie (épidémiologie), Canada (épidémiologie), Chine (épidémiologie), Culture virale, Europe (épidémiologie), Hong Kong (épidémiologie), Hormones corticosurrénaliennes (usage thérapeutique), Humains, Isolement du patient, Maladies transmissibles émergentes (épidémiologie), Oxygène (usage thérapeutique), Pronostic, Ribavirine (usage thérapeutique), Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (transmission), Syndrome respiratoire aigu sévère (virologie), Syndrome respiratoire aigu sévère (épidémiologie), Virus du SRAS (isolement et purification), Virus du SRAS (pathogénicité).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- isolement et purification : Virus du SRAS.
- pathogénicité : Virus du SRAS.
- usage thérapeutique : Antiviraux, Hormones corticosurrénaliennes, Oxygène, Ribavirine, Syndrome respiratoire aigu sévère.
- virologie : Syndrome respiratoire aigu sévère.
- épidémiologie : Asie, Canada, Chine, Europe, Hong Kong, Maladies transmissibles émergentes, Syndrome respiratoire aigu sévère.
- Animaux, Culture virale, Humains, Isolement du patient, Pronostic, Syndrome respiratoire aigu sévère.
- Wicri :
- geographic : Canada, République populaire de Chine, Hong Kong.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (therapeutic use), Animals, Antiviral Agents (therapeutic use), Asia (epidemiology), Canada (epidemiology), China (epidemiology), Communicable Diseases, Emerging (epidemiology), Europe (epidemiology), Hong Kong (epidemiology), Humans, Oxygen (therapeutic use), Patient Isolation, Prognosis, Ribavirin (therapeutic use), SARS Virus (isolation & purification), SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (therapy), Severe Acute Respiratory Syndrome (transmission), Severe Acute Respiratory Syndrome (virology), Virus Cultivation.
- MESH :
- chemical , therapeutic use : Adrenal Cortex Hormones, Antiviral Agents, Oxygen, Ribavirin.
- geographic , epidemiology : Asia, Canada, China, Europe, Hong Kong.
- diagnosis : Severe Acute Respiratory Syndrome.
- epidemiology : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- pathogenicity : SARS Virus.
- therapy : Severe Acute Respiratory Syndrome.
- transmission : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome.
- Animals, Humans, Patient Isolation, Prognosis, Virus Cultivation.
Abstract
INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly.
DOI: 10.1016/s0755-4982(04)98581-8
PubMed: 15041887
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15041887Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].</title><author><name sortKey="Guihot, Amelie" sort="Guihot, Amelie" uniqKey="Guihot A" first="Amélie" last="Guihot">Amélie Guihot</name><affiliation wicri:level="3"><nlm:affiliation>Service de maladies infectieuses et tropicales, hôpital Pitié-Salpêtrière, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>Service de maladies infectieuses et tropicales, hôpital Pitié-Salpêtrière</wicri:orgArea></affiliation></author><author><name sortKey="Bricaire, Francois" sort="Bricaire, Francois" uniqKey="Bricaire F" first="François" last="Bricaire">François Bricaire</name></author><author><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name></author><author><name sortKey="Bossi, Philippe" sort="Bossi, Philippe" uniqKey="Bossi P" first="Philippe" last="Bossi">Philippe Bossi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15041887</idno><idno type="pmid">15041887</idno><idno type="doi">10.1016/s0755-4982(04)98581-8</idno><idno type="wicri:Area/PubMed/Corpus">002E86</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002E86</idno><idno type="wicri:Area/PubMed/Curation">002E86</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002E86</idno><idno type="wicri:Area/PubMed/Checkpoint">002883</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002883</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].</title><author><name sortKey="Guihot, Amelie" sort="Guihot, Amelie" uniqKey="Guihot A" first="Amélie" last="Guihot">Amélie Guihot</name><affiliation wicri:level="3"><nlm:affiliation>Service de maladies infectieuses et tropicales, hôpital Pitié-Salpêtrière, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>Service de maladies infectieuses et tropicales, hôpital Pitié-Salpêtrière</wicri:orgArea></affiliation></author><author><name sortKey="Bricaire, Francois" sort="Bricaire, Francois" uniqKey="Bricaire F" first="François" last="Bricaire">François Bricaire</name></author><author><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name></author><author><name sortKey="Bossi, Philippe" sort="Bossi, Philippe" uniqKey="Bossi P" first="Philippe" last="Bossi">Philippe Bossi</name></author></analytic><series><title level="j">Presse medicale (Paris, France : 1983)</title><idno type="ISSN">0755-4982</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (therapeutic use)</term><term>Animals</term><term>Antiviral Agents (therapeutic use)</term><term>Asia (epidemiology)</term><term>Canada (epidemiology)</term><term>China (epidemiology)</term><term>Communicable Diseases, Emerging (epidemiology)</term><term>Europe (epidemiology)</term><term>Hong Kong (epidemiology)</term><term>Humans</term><term>Oxygen (therapeutic use)</term><term>Patient Isolation</term><term>Prognosis</term><term>Ribavirin (therapeutic use)</term><term>SARS Virus (isolation & purification)</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (therapy)</term><term>Severe Acute Respiratory Syndrome (transmission)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Virus Cultivation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (usage thérapeutique)</term><term>Asie (épidémiologie)</term><term>Canada (épidémiologie)</term><term>Chine (épidémiologie)</term><term>Culture virale</term><term>Europe (épidémiologie)</term><term>Hong Kong (épidémiologie)</term><term>Hormones corticosurrénaliennes (usage thérapeutique)</term><term>Humains</term><term>Isolement du patient</term><term>Maladies transmissibles émergentes (épidémiologie)</term><term>Oxygène (usage thérapeutique)</term><term>Pronostic</term><term>Ribavirine (usage thérapeutique)</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (transmission)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Virus du SRAS (isolement et purification)</term><term>Virus du SRAS (pathogénicité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Antiviral Agents</term><term>Oxygen</term><term>Ribavirin</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Asia</term><term>Canada</term><term>China</term><term>Europe</term><term>Hong Kong</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases, Emerging</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term><term>Hormones corticosurrénaliennes</term><term>Oxygène</term><term>Ribavirine</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Asie</term><term>Canada</term><term>Chine</term><term>Europe</term><term>Hong Kong</term><term>Maladies transmissibles émergentes</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Patient Isolation</term><term>Prognosis</term><term>Virus Cultivation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Culture virale</term><term>Humains</term><term>Isolement du patient</term><term>Pronostic</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>République populaire de Chine</term><term>Hong Kong</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15041887</PMID><DateCompleted><Year>2004</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0755-4982</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>5</Issue><PubDate><Year>2004</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Presse medicale (Paris, France : 1983)</Title><ISOAbbreviation>Presse Med</ISOAbbreviation></Journal><ArticleTitle>[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].</ArticleTitle><Pagination><MedlinePgn>344-51</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly.</AbstractText><AbstractText Label="CLINICAL PRESENTATION AND TREATMENT" NlmCategory="UNASSIGNED">The clinical presentation is highly variable, from a mild fever to an acute respiratory distress syndrome. There is no specific treatment. Ribavirin associated with steroids have been used with success in numerous cases.</AbstractText><AbstractText Label="EPIDEMIOLOGY" NlmCategory="BACKGROUND">During the first half of 2003, the spreading of the virus has been very fast, with a pandemic mode of evolution. More than 8,000 people were infected and 774 died. The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China during January 2004.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guihot</LastName><ForeName>Amélie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de maladies infectieuses et tropicales, hôpital Pitié-Salpêtrière, Paris.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bricaire</LastName><ForeName>François</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Taisheng</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bossi</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Syndrome respiratoire aigu sévère: une épidémie singulière de pneumonie virale.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Presse Med</MedlineTA><NlmUniqueID>8302490</NlmUniqueID><ISSNLinking>0755-4982</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>49717AWG6K</RegistryNumber><NameOfSubstance UI="D012254">Ribavirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010356" MajorTopicYN="N">Patient Isolation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012254" MajorTopicYN="N">Ribavirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="Y">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>31</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15041887</ArticleId><ArticleId IdType="pii">S0755-4982(04)98581-8</ArticleId><ArticleId IdType="doi">10.1016/s0755-4982(04)98581-8</ArticleId><ArticleId IdType="pmc">PMC7135803</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Respir Crit Care Med. 2003 Jul 1;168(1):7-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12773318</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 17;361(9370):1701-3</Citation><ArticleIdList><ArticleId IdType="pubmed">12767737</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-720</Citation><ArticleIdList><ArticleId IdType="pubmed">12867568</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):195-200</Citation><ArticleIdList><ArticleId IdType="pubmed">15030682</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Intern Med. 2003 Nov 4;139(9):715-23</Citation><ArticleIdList><ArticleId IdType="pubmed">14597455</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 Oct 30;425(6961):915</Citation><ArticleIdList><ArticleId IdType="pubmed">14586458</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Infect Dis. 2003 Sep 15;37(6):857-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12955652</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Aug 16;362(9383):570-2</Citation><ArticleIdList><ArticleId IdType="pubmed">12932393</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mayo Clin Proc. 2003 Jul;78(7):882-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12839084</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1779-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12781537</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14532176</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2003 Sep;9(9):1064-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14519241</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Virol. 2003 Dec;28(3):239-44</Citation><ArticleIdList><ArticleId IdType="pubmed">14522061</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2003 Nov;9(11):1381-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14718079</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Hum Pathol. 2003 Aug;34(8):743-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14506633</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Radiology. 2003 Aug;228(2):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12759474</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation><ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Antimicrob Agents Chemother. 1986 Aug;30(2):201-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2876677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Bossi, Philippe" sort="Bossi, Philippe" uniqKey="Bossi P" first="Philippe" last="Bossi">Philippe Bossi</name><name sortKey="Bricaire, Francois" sort="Bricaire, Francois" uniqKey="Bricaire F" first="François" last="Bricaire">François Bricaire</name><name sortKey="Li, Taisheng" sort="Li, Taisheng" uniqKey="Li T" first="Taisheng" last="Li">Taisheng Li</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Guihot, Amelie" sort="Guihot, Amelie" uniqKey="Guihot A" first="Amélie" last="Guihot">Amélie Guihot</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002883 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002883 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15041887
|texte= [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15041887" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |